Table 1.
Variables | Group I (n = 25) | Group II (n = 76) | P value |
---|---|---|---|
Sex | |||
Male: Female | 12:13 | 30:46 | 0.453 |
Age (years) | 51.0 ± 10.9 | 43.4 ± 8.9 | 0.003 |
Body mass index (kg/m2) | 31.5 | 33.7 ± 5.7 | 0.072 |
Waist circumference (cm) | 106.5 ± 12.3 | 107.1 ± 9.6 | 0.810 |
Waist-to-height ratio | 0.656 ± 0.070 | 0.651 ± 0.086 | 0.814 |
Triglyceride index | 1.256 ± 0.650 | 1.057 ± 0.521 | 0.171 |
Cholesterol index | 0.880 ± 0.196 | 0.929 ± 0.159 | 0.260 |
Diabetes (no.) | 10 | 17 | 0.084 |
Fasting serum glucose (non-diabetic) | 118.2 ± 30.1 | 107.6 ± 16.3 | 0.203 |
Fasting serum glucose (diabetic) | 146.3 ± 69.6 | 156.7 ± 42.7 | 0.841 |
Alanine aminotransferase (U/L) | 19.1 ± 5.7 | 42.4 ± 21.3 | <0.001 |
Aspartate aminotransferase (U/L) | 18.9 ± 4.3 | 28.5 ± 13.5 | <0.001 |
Alanine/aspartate aminotransferase ratio | 1.053 ± 0.383 | 1.593 ± 0.582 | <0.001 |
Aspartate/alanine aminotransferase ratio | 1.075 ± 0.389 | 0.720 ± 0.279 | <0.001 |
The results are presented as mean ± SD. P values were calculated using the two-tailed independent two-sample t-test for continuous data, and the Chi-square test for discrete data. Group I: patients with risk factors, Group II: patients with non-alcoholic fatty liver disease.